194 related articles for article (PubMed ID: 23279640)
1. Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy.
Lowe MC; Badell IR; Turner AP; Thompson PW; Leopardi FV; Strobert EA; Larsen CP; Kirk AD
Am J Transplant; 2013 Feb; 13(2):312-9. PubMed ID: 23279640
[TBL] [Abstract][Full Text] [Related]
2. Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion.
Lo DJ; Anderson DJ; Weaver TA; Leopardi F; Song M; Farris AB; Strobert EA; Jenkins J; Turgeon NA; Mehta AK; Larsen CP; Kirk AD
Am J Transplant; 2013 Feb; 13(2):320-8. PubMed ID: 23311611
[TBL] [Abstract][Full Text] [Related]
3. Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.
Weaver TA; Charafeddine AH; Agarwal A; Turner AP; Russell M; Leopardi FV; Kampen RL; Stempora L; Song M; Larsen CP; Kirk AD
Nat Med; 2009 Jul; 15(7):746-9. PubMed ID: 19584865
[TBL] [Abstract][Full Text] [Related]
4. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.
Wijkstrom M; Kenyon NS; Kirchhof N; Kenyon NM; Mullon C; Lake P; Cottens S; Ricordi C; Hering BJ
Transplantation; 2004 Mar; 77(6):827-35. PubMed ID: 15077021
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroids and methotrexate as adjuvants to costimulation blockade in non-human primate renal transplantation.
Anderson DJ; Lo DJ; Leopardi F; Song M; Strobert EA; Jenkins JB; Larsen CP; Kirk AD
Clin Transplant; 2019 Jun; 33(6):e13568. PubMed ID: 31006146
[TBL] [Abstract][Full Text] [Related]
6. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.
Thompson P; Cardona K; Russell M; Badell IR; Shaffer V; Korbutt G; Rayat GR; Cano J; Song M; Jiang W; Strobert E; Rajotte R; Pearson T; Kirk AD; Larsen CP
Am J Transplant; 2011 May; 11(5):947-57. PubMed ID: 21521467
[TBL] [Abstract][Full Text] [Related]
7. Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.
Kirk AD; Guasch A; Xu H; Cheeseman J; Mead SI; Ghali A; Mehta AK; Wu D; Gebel H; Bray R; Horan J; Kean LS; Larsen CP; Pearson TC
Am J Transplant; 2014 May; 14(5):1142-51. PubMed ID: 24684552
[TBL] [Abstract][Full Text] [Related]
8. Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.
Lo DJ; Weaver TA; Stempora L; Mehta AK; Ford ML; Larsen CP; Kirk AD
Am J Transplant; 2011 Jan; 11(1):22-33. PubMed ID: 21070604
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression With CD40 Costimulatory Blockade Plus Rapamycin for Simultaneous Islet-Kidney Transplantation in Nonhuman Primates.
Oura T; Hotta K; Lei J; Markmann J; Rosales I; Dehnadi A; Kawai K; Ndishabandi D; Smith RN; Cosimi AB; Kawai T
Am J Transplant; 2017 Mar; 17(3):646-656. PubMed ID: 27501203
[TBL] [Abstract][Full Text] [Related]
10. CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8.
Badell IR; Russell MC; Cardona K; Shaffer VO; Turner AP; Avila JG; Cano JA; Leopardi FV; Song M; Strobert EA; Ford ML; Pearson TC; Kirk AD; Larsen CP
Am J Transplant; 2012 Jul; 12(7):1918-23. PubMed ID: 22458552
[TBL] [Abstract][Full Text] [Related]
11. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
[TBL] [Abstract][Full Text] [Related]
12. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.
Kirk AD; Harlan DM; Armstrong NN; Davis TA; Dong Y; Gray GS; Hong X; Thomas D; Fechner JH; Knechtle SJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8789-94. PubMed ID: 9238056
[TBL] [Abstract][Full Text] [Related]
13. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates.
Adams AB; Shirasugi N; Durham MM; Strobert E; Anderson D; Rees P; Cowan S; Xu H; Blinder Y; Cheung M; Hollenbaugh D; Kenyon NS; Pearson TC; Larsen CP
Diabetes; 2002 Feb; 51(2):265-70. PubMed ID: 11812731
[TBL] [Abstract][Full Text] [Related]
14. Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.
Thompson P; Badell IR; Lowe M; Turner A; Cano J; Avila J; Azimzadeh A; Cheng X; Pierson RN; Johnson B; Robertson J; Song M; Leopardi F; Strobert E; Korbutt G; Rayat G; Rajotte R; Larsen CP; Kirk AD
Am J Transplant; 2012 Jul; 12(7):1765-75. PubMed ID: 22458586
[TBL] [Abstract][Full Text] [Related]
15. Rabbit antithymocyte globulin induction and sirolimus monotherapy supports prolonged islet allograft function in a nonhuman primate islet transplantation model.
Hirshberg B; Preston EH; Xu H; Tal MG; Neeman Z; Bunnell D; Soleimanpour S; Hale DA; Kirk AD; Harlan DM
Transplantation; 2003 Jul; 76(1):55-60. PubMed ID: 12865786
[TBL] [Abstract][Full Text] [Related]
16. LFA-1-specific therapy prolongs allograft survival in rhesus macaques.
Badell IR; Russell MC; Thompson PW; Turner AP; Weaver TA; Robertson JM; Avila JG; Cano JA; Johnson BE; Song M; Leopardi FV; Swygert S; Strobert EA; Ford ML; Kirk AD; Larsen CP
J Clin Invest; 2010 Dec; 120(12):4520-31. PubMed ID: 21099108
[TBL] [Abstract][Full Text] [Related]
17. Anti-thymoglobulin induction improves neonatal porcine xenoislet engraftment and survival.
Gao Q; Davis R; Fitch Z; Mulvihill M; Ezekian B; Schroder P; Schmitz R; Song M; Leopardi F; Ribeiro M; Miller A; Moris D; Shaw B; Samy K; Reimann K; Williams K; Collins B; Kirk AD
Xenotransplantation; 2021 Nov; 28(6):e12713. PubMed ID: 34951057
[TBL] [Abstract][Full Text] [Related]
18. The effect of epitope-based ligation of ICAM-1 on survival and retransplantation of pig islets in nonhuman primates.
Lee JI; Kim J; Choi YJ; Park HJ; Park HJ; Wi HJ; Yoon S; Shin JS; Park JK; Jung KC; Lee EB; Kang HJ; Hwang ES; Kim SJ; Park CG; Park SH
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29131413
[TBL] [Abstract][Full Text] [Related]
19. Islet transplantation in type 1 diabetic patients using calcineurin inhibitor-free immunosuppressive protocols based on T-cell adhesion or costimulation blockade.
Posselt AM; Szot GL; Frassetto LA; Masharani U; Tavakol M; Amin R; McElroy J; Ramos MD; Kerlan RK; Fong L; Vincenti F; Bluestone JA; Stock PG
Transplantation; 2010 Dec; 90(12):1595-601. PubMed ID: 20978464
[TBL] [Abstract][Full Text] [Related]
20. Biological agents in kidney transplantation: belatacept is entering the field.
Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
Expert Opin Biol Ther; 2010 Oct; 10(10):1501-8. PubMed ID: 20726688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
